This study investigates the levels of progastrin in patients with various types of cancer, including breast, gastric, renal, prostate, lung, and others. Progastrin is a substance that can be found in the blood of cancer patients and is linked to a pathway involved in cancer development.
The purpose of this study is to evaluate how progastrin levels change during treatment and how these levels might predict the progress and outcomes of the disease. This could provide important information for diagnosing and understanding the prognosis of cancer patients.
- Who can participate: Adults over 18 years may participate. Participants must provide informed consent and be part of a social insurance program.
- Study details: Participants will have their blood tested for progastrin levels to track changes during treatment. Some participants may receive treatments like surgery or chemotherapy.
How understandable was the trial content above?
Hard to understand
Easy to understand